In a peer-reviewed medical case report, researchers describe the clinical presentation and diagnostic evaluation of a 46-year-old male patient with multiple sclerosis whose rapidly worsening, memory-predominant cognitive decline closely mimicked progression independent of relapse activity, but was ultimately identified as comorbid early-onset Alzheimer’s disease. The patient possessed a ten-year established clinical history of multiple sclerosis and presented with severe cognitive deficits that had developed continuously over the preceding five years. Despite the complete absence of clinical relapses and only limited inflammatory activity on magnetic resonance imaging, his cognitive impairment advanced steadily and was distinctly disproportionate to his physical disability, presenting a deceptive diagnostic presentation resembling cognitive relapse-independent progression.
Cognitive impairment represents a common and disabling clinical feature of multiple sclerosis that is increasingly recognized as an important manifestation of progression independent of relapse activity, commonly termed cognitive PIRA. Recent research investigations have characterized cognitive PIRA as a gradual, relapse-independent decline in cognitive performance identified through longitudinal neuropsychological assessments, most commonly affecting information processing speed as its primary manifestation. However, distinguishing genuine multiple sclerosis-related cognitive PIRA from concurrent neurodegenerative disorders presents a profound diagnostic challenge in routine clinical neurology.
When evaluated through formal neuropsychological testing, the patient revealed an early amnestic-dominant profile characterized primarily by memory loss, directly contrasting with the processing speed-predominant pattern classically observed in multiple sclerosis-related cognitive impairment. In an attempt to manage the worsening condition, clinical treatment was escalated from baseline interferon-beta-1a therapy to ofatumumab, a high-efficacy anti-CD20 disease-modifying therapy. Despite the escalation to this intensive immunotherapy, the patient’s cognitive deterioration persisted unabated over time, arguing strongly against ongoing inflammatory disease activity as the primary driver responsible for the progressive cognitive decline.
Serial magnetic resonance imaging evaluations demonstrated progressive cerebral atrophy affecting both the corpus callosum and the parietal lobes, occurring notably without the development of any new white matter lesions characteristic of multiple sclerosis activity.
Cerebrospinal fluid analysis demonstrated a significantly reduced amyloid-beta 1–42 to amyloid-beta 1–40 ratio accompanied by elevated levels of phosphorylated tau protein, establishing a biomarker profile directly consistent with Alzheimer’s disease pathology. By synthesizing the patient’s rapid five-year clinical course, the amnestic-dominant neuropsychological profile, the structural and functional neuroimaging findings showing parietal and cingulate involvement, and the confirmatory cerebrospinal fluid biomarker measurements, the clinical team determined that comorbid early-onset Alzheimer’s disease was the predominant primary cause of the severe cognitive decline.
The case report highlights a critical diagnostic pitfall in the long-term management of multiple sclerosis: rapidly progressive, memory-predominant cognitive impairment may represent a deceptive cognitive PIRA mimic rather than genuine multiple sclerosis-related progression. Based on these findings, the authors emphasize that clinicians should actively consider the possibility of comorbid Alzheimer’s disease whenever cognitive decline follows an amnestic-dominant pattern, proceeds disproportionately to the patient’s degree of physical disability, and proves completely unresponsive to escalation with high-efficacy disease-modifying therapies such as anti-CD20 agents.
Subject of Research: Early-onset Alzheimer's disease presenting as a cognitive progression mimic in multiple sclerosis
Article Title: Early-onset Alzheimer’s disease mimicking cognitive progression independent of relapse activity in multiple sclerosis: a case report and diagnostic strategy
Article References: Ueno, T., Miura, M., Hiyama, K., Yanagida, R., Kinoshita, I., Haga, R., & Arai, A. (2026). Early-onset Alzheimer’s disease mimicking cognitive progression independent of relapse activity in multiple sclerosis: a case report and diagnostic strategy. BMC Neurology. https://doi.org/10.1186/s12883-026-05474-4
Image Credits: AI Generated
DOI: 10.1186/s12883-026-05474-4
Keywords: multiple sclerosis, early-onset Alzheimer's disease, cognitive impairment, progression independent of relapse activity, neuropsychological assessment, cerebrospinal fluid biomarkers, case report, neuroimaging, Early-onset, Alzheimer, disease, mimicking
News Source: Diana Fleming. (November 10, 2026). Early Alzheimer’s Disease Mimicked Cognitive Progression in Multiple Sclerosis Case. Scienmag.



